Acquisition (code A) of 4,211 shares at $1.47 per share.
Reporting Person Faller Douglas Vincent · Officer Title Chief Medical Officer · Transaction Code A
Traded Sep 11, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001437749-26-030413 · filed 2026-09-15 · View filing →
Acquisition (code A) of 5,504 shares at $1.47 per share.
Reporting Person Lindborg Stacy · Officer Title President and CEO · Transaction Code A
Traded Sep 11, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001437749-26-030414 · filed 2026-09-15 · View filing →
Acquisition (code A) of 5,824 shares at $1.47 per share.
Reporting Person Tardugno Michael H · Officer Title Executive Chairman of Board · Transaction Code A
Traded Sep 11, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001437749-26-030415 · filed 2026-09-15 · View filing →
Sale of 2,525 shares at $1.5643 per share.
Reporting Person Eylward Susan · Officer Title General Counsel and Corp Sec · Transaction Code S
Traded Aug 31, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001437749-26-029405 · filed 2026-09-01 · View filing →
Acquisition (code A) of 2,525 shares at $1.60 per share.
Reporting Person Eylward Susan · Officer Title General Counsel and Corp Sec · Transaction Code A
Traded Aug 28, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001437749-26-029405 · filed 2026-09-01 · View filing →
Acquisition (code A) of 3,626 shares at $1.60 per share.
Reporting Person Faller Douglas Vincent · Officer Title Chief Medical Officer · Transaction Code A
Traded Aug 28, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001437749-26-029407 · filed 2026-09-01 · View filing →
Acquisition (code A) of 6,822 shares at $1.60 per share.
Reporting Person Lindborg Stacy · Officer Title President and CEO · Transaction Code A
Traded Aug 28, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001437749-26-029408 · filed 2026-09-01 · View filing →
Acquisition (code A) of 7,371 shares at $1.60 per share.
Reporting Person Tardugno Michael H · Officer Title Executive Chairman of Board · Transaction Code A
Traded Aug 28, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001437749-26-029409 · filed 2026-09-01 · View filing →
Sale of 2,449 shares at $1.6303 per share.
Reporting Person Eylward Susan · Officer Title General Counsel and Corp Sec · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001437749-26-028184 · filed 2026-08-17 · View filing →
Acquisition (code A) of 2,449 shares at $1.65 per share.
Reporting Person Eylward Susan · Officer Title General Counsel and Corp Sec · Transaction Code A
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001437749-26-028184 · filed 2026-08-17 · View filing →
Acquisition (code A) of 7,147 shares at $1.65 per share.
Reporting Person Tardugno Michael H · Officer Title Executive Chairman of Board · Transaction Code A
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001437749-26-028185 · filed 2026-08-17 · View filing →
Acquisition (code A) of 3,516 shares at $1.65 per share.
Reporting Person Faller Douglas Vincent · Officer Title Chief Medical Officer · Transaction Code A
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001437749-26-028186 · filed 2026-08-17 · View filing →
Acquisition (code A) of 6,615 shares at $1.65 per share.
Reporting Person Lindborg Stacy · Officer Title President and CEO · Transaction Code A
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001437749-26-028187 · filed 2026-08-17 · View filing →